Uveitis is a rare inflammatory disease of the choroid of the eye, which lies between the retina and the sclera. "Depending on ...

Uveitis is a serious and sometimes painful eye condition that shouldn't be ignored. It's caused by inflammation in the uvea, a layer of tissue just inside the outer white part of your eye.

Uveitis is uncommon in patients with multiple sclerosis (MS), but the link between the two entities is clearly established. While a common etiology or pathologic process remains unknown ...

Infliximab is more effective and safer than etanercept in the treatment of patients with noninfectious uveitis. Adalimumab is valid for severe uveitis, reducing efficacy for treatment of infliximab.

and the advancement of brepocitinib to Phase 3 trials for non-infectious uveitis, a form of eye inflammation. Roivant ...

Ocular autoimmune disease involves the immune system attacking the tissues of the eye. These diseases typically manifest through an autoantibody response targeting the retina, uvea, vitreous, and ...

Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001to treat uveitic ...

The company’s lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis ...

Q2 2024 Earnings Call Transcript November 12, 2024 Operator: Good day and thank you for standing by. Welcome to the Roivant ...

Topline data from Phase 2b/3 trial of izokibep as a treatment for non-infectious non-anterior uveitis expected in December 2024 Positive lonigutamab EOP2 FDA interaction completed and initiation of ...

Shelley Kline has spent four decades dealing with pain, medication, and traumatic procedures for her eye disease. She knows ...

and for non-infectious anterior uveitis; and OCS-05, a neuroprotective candidate for acute optic neuritis (AON). Headquartered in Switzerland and with operations in the U.S. and Iceland, Oculis’ goal ...